LG-GDCL002

Brief Summary:

The aim of this 12-week randomized multicenter double-blind double-dummy parallel group placebo and active comparator-controlled dose finding study is to assess the efficacy and safety of three different doses of LC350189 in subjects with hyperuricemia and a diagnosis of gout.

View The Flyer For This Study

Click Here For More Information

 

 

INTERESTED IN THIS STUDY?  CLICK HERE TO CONTACT US.